Elevated mortality rates from circulatory disease in African American men and women of Los Angeles County, California - A possible genetic susceptibility

American Journal of the Medical Sciences

Volumn 320, Issue 1, 2000, Pages 18-23

  Henderson, Sean O ^b   Coetzee, Gerhard A ^a   Ross, Ronald K ^a   Yu, Mimi C ^a   Henderson, Brian E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Angiotensin converting enzyme; Cardiovascular; Hypertension; Mortality

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; UNITED STATES;

EID: 0033928516     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40793-1     Document Type: Article

References (45)

1. American Heart Association. Cardiovascular diseases and stroke in African-Americans and other racial minorities in the United States: a statement for health professionals. Circulation 1991;83:1462-80.
2. Becker LB, Han BH, Meyer PM, et al. Racial differences in the incidence of cardiac arrest and subsequent survival. N Engl J Med 1993;329:600-6.
3. Otten MW, Teutsch SM, Williamson DF, et al. The effect of known risk factors on the excess mortality of black adults in the United States. JAMA 1990;263:845-50.
4. Keil JE, Sutherland SE, Knapp RG, et al. Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med 1993;329:73-8.
5. Fang J, Madhavan S, Alderman MH. The association between birthplace and mortality from cardiovascular causes among black and white residents in New York City. N Engl J Med 1996;335:1545-51.
6. Duru K, Farrow S, Wang JM, et al. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African Americans with Hypertension. Am J Hypertens 1994;7:759-762.
7. Weir MR, Gray JM, Paster R, et al. Differing mechanism of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 1995;24:124-30.
8. Kolonel LN, Henderson BE, Hankin JH, et al. A multi-ethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-57.
9. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1443.
10. Breslow NE, Day NE. Statistical methods of cancer research: volume II - the design and analysis of cohort studies. IARC Scientific Publications No. 82. Lyon, France: International Agency for Research on Cancer; 1987.
11. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames, Iowa: The Iowa State University Press; 1967.
12. Wild SH, Laws A, Fortmann SP, et al. Mortality for coronary heart disease and stroke for six ethnic groups in California, 1985-1990. Ann Epidemiol 1995:5:432-9.
13. Pappas G, Queen S, Hadden W, et al. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med 1993;329:103-9.
14. Geronimus AT, Bound J, Waidmann TA, et al. Excess mortality among blacks and whites in the United States. N Engl J Med 1996;335:1552-8.
15. Davey Smith G, Neaton JD, Wentworth D, et al. Mortality differences between black and white men in the contribution of income and other risk factors among men screened for the MRFIT. Lancet 1998;351:934-9.
16. Shea S, Misra D, Ehrlich MH, et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992;327:776-81.
17. Johnson PA, Lee TH, Cook EF, et al. Effect of race on the presentation and management of patients with acute chest pain. Ann Int Med 1993;118:593-601.
18. Whittle J, Conigliaro J, Good CB, et al. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med 1993;329:621-7.
19. Norris SL, de Guzman M, Sobel E, et al. Risk factors and mortality among black, Caucasian, and Latino women with acute myocardial infarction. Am Heart J 1993;126:1312-9.
20. Census of Population and Housing. Population and housing characteristics for census tracts and block numbering areas. Los Angeles - Anaheim - Riverside, CA. Washington (DC): Bureau of the Census, Economics and Statistics Administration, United States Dept. of Commerce; 1990. p. 3361-3812.
21. Sprafka JM, Folsom AR, Burke GL, et al. Prevalence of cardiovascular disease risk factors in blacks and whites: the Minnesota heart survey. Am J Public Health 1988;78: 1546-9.
22. Hohn AR, Dwyer KM, Dwyer JH. Blood pressure in youth from four ethnic groups: the Pasadena prevention project. J Pediatr 1994;125:368-73.
23. Goldring D, Londe S, Sivakoff M, et al. Blood pressure in a high school population. J Pediatr 1977;91:884-9.
24. Pratt JH, Jones JJ, Miller JZ, et al. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med 1989;321:1152-7.
25. Cooper R, Rotimi C. Hypertension in populations of West African origin: is there a genetic predisposition? J Hypertens 1994;12:215-27.
26. Kaufman JS, Owoaje EE, James SA, et al. Determinants of hypertension in West Africa: contribution of anthropometric and dietary factors to urban-rural and socioeconomic gradients. Am J Epidemiol 1996;143:1203-18.
27. Seedat YK, Seedat MA, Hackland DB. Biosocial factors and hypertension in urban and rural Zulus. S Afr Med J 1982;61:999-1002.
28. Seedat YK, Seedat MA, Hackland DB. Prevalence of hypertension in the urban and rural Zulu. J Epidemiol Community Health 1982;36:256-61.
29. Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-25.
30. Daemen JMAP, Lomarbardi DM, Bosman FT, et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-6.
31. Rigat B, Hubert C, Alhene-Gelas F, et al. An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
32. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-202.
33. Mastana S, Nunn J. Angiotensin-converting enzyme deletion polymorphism is associated with hypertension in a Sikh population. Hum Hered 1997;47:250-3.
34. Prasad N, O'Kane KPJ, Johnstone HA, et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. Q J Med 1994;87:659-62.
35. Raynolds MV, Bristow MR, Bush EW, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342: 1073-5.
36. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
37. Mattu RK, Needham EW, Galton DJ, et al. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995;91:270-274.
38. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
39. Lindpainter K, Lee M, Larson MG, et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996;334:1023-8.
40. Harrap SB, Davidson RJ, Connor JM, et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993;21:455-60.
41. Asamoah A, Yanamandra K, Thurmon TF, et al. A deletion in the angiotensin converting enzyme (ACE) gene is common among African Americans with essential hypertension. Clin Chim Acta 1996;254:41-6.
42. Rotimi C, Puras A, Cooper R, et al. Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans and African Americans. Hypertension 1996;27(3 Pt 2):558-63.
43. Barley J, Blackwood A, Carter ND, et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994;12:955-7.
44. Bloem LJ, Manatunga AK, Pratt JH. Racial Difference in the relationship of an angiotensin-I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996;27:62-6.
45. Forrester T, McFarlane-Anderson N, Bennett FI, et al. The angiotensin converting enzyme and blood pressure in Jamaicans. Am J Hypertens 1997;10:519-24.